C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 116 filers reported holding C4 THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22 | -37.1% | 11,921 | -6.9% | 0.00% | – |
| Q2 2023 | $35 | -60.2% | 12,810 | -54.3% | 0.00% | -100.0% |
| Q1 2023 | $88 | -64.1% | 28,013 | -32.6% | 0.00% | -66.7% |
| Q4 2022 | $245 | -99.9% | 41,545 | +5.3% | 0.00% | -25.0% |
| Q3 2022 | $346,000 | +44.8% | 39,458 | +24.6% | 0.00% | +33.3% |
| Q2 2022 | $239,000 | +3.9% | 31,673 | +343.0% | 0.00% | +200.0% |
| Q4 2021 | $230,000 | -56.2% | 7,149 | -39.1% | 0.00% | -50.0% |
| Q3 2021 | $525,000 | +224.1% | 11,741 | +173.7% | 0.00% | +100.0% |
| Q2 2021 | $162,000 | +10.2% | 4,290 | +8.0% | 0.00% | 0.0% |
| Q1 2021 | $147,000 | – | 3,972 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,642,210 | $39,840,000 | 3.87% |
| Paradigm Biocapital Advisors LP | 499,496 | $12,118,000 | 3.20% |
| Cypress Point Wealth Management, LLC | 118,573 | $2,877,000 | 2.92% |
| COMMODORE CAPITAL LP | 481,094 | $11,671,000 | 2.61% |
| Nextech Invest Ltd. | 375,857 | $9,118,000 | 2.60% |
| RTW INVESTMENTS, LP | 4,531,982 | $109,946,000 | 2.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 362,528 | $8,795,000 | 1.24% |
| Perceptive Advisors | 2,082,723 | $50,526,000 | 1.01% |
| CLOUGH CAPITAL PARTNERS L P | 356,181 | $8,641,000 | 0.66% |
| HighVista Strategies LLC | 34,760 | $843,000 | 0.54% |